Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Discover intelligent digital solutions to help improve outcomes, manage costs, and solve the toughest healthcare challenges.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Financial modeling & industrialization
Insurance risk assessment
Retirement & Benefits
Deliver on the promises of the past and create smart solutions for the future.
Compensations & benefits
Benefit plan evaluation
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
Auto policy underwriting
Software performance enhancement
Mortgage platform for investments & reinsurance
Solvency II reporting & compliance
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Over the past two years, collateralised reinsurance has displaced catastrophe bonds as the fastest-growing area of insurance-linked investing. The private, customisable nature of collateralised reinsurance deals provides investors and cedents with significant flexibility, but also produces a largely illiquid and oftentimes hard-to-value investment.
This rise in collateralised reinsurance makes having a robust, independent valuation process in place even more important. There are a number of ways in which Milliman can partner with investors to ensure a transparent and effective valuation process for collateralised reinsurance.
Hedge funds that specialise in catastrophe-linked investing have seen a rise in the concentration of collateralised reinsurance in their portfolios, which can make valuation and performance tracking more difficult. As a result, it can be more difficult for these funds to provide a robust level of transparency when reporting the NAV of their holdings. Milliman can provide an independent estimate of NAV, allowing funds to improve the quality of their reporting and show their commitment to their investors.
Milliman can also partner with funds to perform an independent review of their existing valuation processes and analyses. Primarily, this entails a review of the techniques and workpapers used by the fund in their valuation process to estimate the NAV of their portfolios. The operational aspects of the process are reviewed through interviews and interaction with the key personnel (underwriters, modelers, and managers) involved in the valuation process. Past experience and industry benchmarks are used to help funds build and maintain a best-practices valuation and reporting process.
Aaron Koch is a principal and consulting actuary based in Northern Virginia. He joined Milliman in 2011.
Ask the tough questions. We’re ready for them.